These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 13524526)

  • 21. [Several tests of toxohormone activity].
    Schmidt F; Friedrich M
    Arch Geschwulstforsch; 1965; 26(2):89-94. PubMed ID: 5882883
    [No Abstract]   [Full Text] [Related]  

  • 22. [Blood serum cholinesterase activity in oncological diseases].
    Iriskhanov KhA; Tazuev ASh; Kekharsaeva ER; Didaeva TS
    Lab Delo; 1984; (9):551-3. PubMed ID: 6210408
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationship of ABO blood groups to certain types of cancer common in Western India.
    Jayant K
    Indian J Cancer; 1971 Sep; 8(3):185-8. PubMed ID: 5141723
    [No Abstract]   [Full Text] [Related]  

  • 24. Host-tumour relationship. XXIX. Hyaluronidase activity and seromucoid concentration in blood serum of patients with cancer.
    Kolárová M; Tobiska J; Brada Z
    Neoplasma; 1970; 17(6):641-8. PubMed ID: 5534086
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum cathepsin activity in patients with malignant neoplastic diseases.
    Kucharz E; Rusinowska Z; Nowak M
    Med Interne; 1986; 24(2):121-3. PubMed ID: 3726423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arginine content in serum protein and in serum protein fractions in cases of neoplastic disease.
    Farbiszewski R; Worowski K; Rzeczycki W
    Neoplasma; 1971; 18(2):179-83. PubMed ID: 5103639
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ganglioside GD3 in the serum of tumor patients].
    Diatlovitskaia EV; Somova OG; Novikov AM; Sorokin EN; Bassalyk LS
    Biokhimiia; 1985 Nov; 50(11):1933-5. PubMed ID: 3904839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of UV-irradiation on human serum under normal and pathologic conditions].
    Kulikov VIu; Kaznacheev VP; Kolesnikova LI
    Biull Eksp Biol Med; 1977 Apr; 83(4):427-9. PubMed ID: 857969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A method of diagnosing malignant neoplasms based on the natural fluorescence of the blood serum in the ultraviolet and visible regions of the spectrum].
    Grigorovich NA; Slobozhanina EI; Monastyrnaia PL; Chernitskiĭ EA
    Vopr Onkol; 1988; 34(6):664-8. PubMed ID: 3394266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Electrophoretic separation of serum proteins in tumor patients].
    Goriukhina TA; Cherenkovskaia IA; Sinitsina NI
    Vopr Onkol; 1966 Apr; 12(4):46-50. PubMed ID: 5245208
    [No Abstract]   [Full Text] [Related]  

  • 31. [Some in vitro experiments with toxohormone].
    MIYAJIMA S
    Gan; 1956 Dec; 47(3-4):304-6. PubMed ID: 13415012
    [No Abstract]   [Full Text] [Related]  

  • 32. [The purification of toxohormone].
    ONO T; UMEDA M; SUGIMURA T
    Gan; 1956 Dec; 47(3-4):302-3. PubMed ID: 13415011
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the mechanism of toxohormone function. II.
    HOSHIZIMA H
    Gan; 1958 Sep; 49(3):171-6. PubMed ID: 13609802
    [No Abstract]   [Full Text] [Related]  

  • 34. [Characteristics of the serum proteins of cancer patients in an acid medium].
    Ivanov AP; Korotkoruchko VP; Nizhinkovskaia TN
    Ukr Biokhim Zh; 1977; 49(2):63-7. PubMed ID: 17208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dry drop of blood plasma--a new approach in the diagnosis of neoplastic diseases.
    Brzecki A; Brzecka A; Gruszka E; Olejniczak P; Cyrul M
    Mater Med Pol; 1989; 21(3):170-3. PubMed ID: 2491267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A contribution to the biological determination of toxohormone or liver catalase reducing factor].
    SHINAGAWA S; KIMURA S; TAGUCHI K
    Gan; 1957 Dec; 48(4):602-4. PubMed ID: 13524527
    [No Abstract]   [Full Text] [Related]  

  • 37. Quantitative indicators of neoplastic activity.
    HUGGINS C; JENSEN EV; BAKER R
    Acta Unio Int Contra Cancrum; 1953; 9(4):752-6. PubMed ID: 13138339
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determination of protein in blood serum in patients with malignant neoplasms].
    MADIEVSKII IuM
    Klin Med (Mosk); 1957 Jun; 35(6):43-6. PubMed ID: 13450159
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum cholinesterase activity in malignant neoplasms.
    WETSTONE H; LAMOTTA R; WHITE BV
    Trans Am Clin Climatol Assoc; 1957-1958; 69():176-81. PubMed ID: 13581099
    [No Abstract]   [Full Text] [Related]  

  • 40. [On electrophoretic changes in proteins and lipoproteins in the blood serum in malignant neoplasms].
    ATAMANOV GS; SAPEROV VN
    Sov Med; 1961 May; 25():80-6. PubMed ID: 13684929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.